2020
DOI: 10.1097/icl.0000000000000644
|View full text |Cite
|
Sign up to set email alerts
|

Tear Organic Acid Analysis After Corneal Collagen Crosslinking in Keratoconus

Abstract: Objectives: This study examined changes in the levels of organic acids, which are important tear metabolites, after corneal collagen crosslinking (CXL) treatment for keratoconus. Methods: This prospective, nonrandomized, interventional case series included a single eye from 24 patients who were scheduled to receive CXL treatment (Dresden protocol) for progressive keratoconus. Before CXL treatment and at 6 months after treatment, tears were collected in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 31 publications
0
7
0
Order By: Relevance
“…Two studies did not report any significant age-related effect on the ω3:ω6 (proinflammatory/antiinflammatory) lipid ratio in tears 88 nor on amino acids 53 whereas most studies found that concentrations of both lipids 48,3,5 and metabolites 76,43 were influenced by age.Other factors (e.g.…”
Section: B) Other Factors Influencing Tear Metabolome and Lipidomementioning
confidence: 94%
See 1 more Smart Citation
“…Two studies did not report any significant age-related effect on the ω3:ω6 (proinflammatory/antiinflammatory) lipid ratio in tears 88 nor on amino acids 53 whereas most studies found that concentrations of both lipids 48,3,5 and metabolites 76,43 were influenced by age.Other factors (e.g.…”
Section: B) Other Factors Influencing Tear Metabolome and Lipidomementioning
confidence: 94%
“…Cross-linking is part of the therapeutic arsenal, but its efficacy remains controversial 69 . One study investigated the metabolomics profile using LC-MS/MS in the pre-and 6 months post-cross-linking basal tears of patients with keratoconus based on the Rabinowitz diagnosis criteria 76 . In total, 24 metabolites were identified, among which 7 were significantly up-regulated (univariate analyses: 4-OH phenylacetic acid (p<0.01), fumaric acid (p<0.05), glycolic acid (p<0.01), homogentisic acid (p<0.05), N-acetyl-Laspartic acid (p<0.0001), 2-OH phenylacetic acid (p<0.01), and suberic acid (p<0.01)) and 4 were significantly down-regulated (univariate analyses: 3-OH butyric acid (p<0.01), pyruvic acid (p<0.05), 2-OH-3-methyl pentanoic acid (p<0.05), and 2-ketoglutaric acid (p<0.01)).…”
Section: Longitudinal Investigationsmentioning
confidence: 99%
“…Riboflavin-mediated crosslinking is an FDA-approved treatment for KC that also promotes lower lactate/malate levels in tears [ 99 ] and reduced lactate production by corneal fibroblasts [ 100 ], providing a degree of stabilization to the metabolic phenotype observed in KC, in addition to stiffening the collagen matrix to blunt progressive thinning. Moreover, basal arginase activity and hydroxyproline levels have been found to be lower in KC-derived keratocytes [ 101 ], correlating with a reduction in collagen deposition associated with these cells [ 102 ].…”
Section: Corneamentioning
confidence: 99%
“…The tear metabolic status of patients who had progressive keratoconus was also examined before and after CXL. An increase was found in 16 organic acids and a decrease in 8 organic acids 6 months after CXL treatment [ 86 ]. The organic acid that showed the greatest percentage increase before and after CXL was N-acetyl-L-aspartic acid, a derivative of aspartic acid that has anti-oxidant effects.…”
Section: Keratoconusmentioning
confidence: 99%